HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

namitecan

has antineoplastic activity; structure in first source
Also Known As:
ST 1968; ST-1968; ST1968; (4S)-11-((E)-((2-aminoethoxy)imino)methyl)-4-ethyl-4-hydroxy-1,12-dihydro-14H-pyrano(3',4':6,7)indolizino(1,2-b)quinoline-3,14(4H)-dione
Networked: 8 relevant articles (2 outcomes, 5 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Pisano, Claudio: 6 articles (02/2014 - 06/2008)
2. Zuco, Valentina: 5 articles (02/2014 - 06/2008)
3. Zunino, Franco: 5 articles (02/2014 - 06/2008)
4. De Cesare, Michelandrea: 4 articles (02/2014 - 06/2008)
5. Bucci, Federica: 4 articles (12/2012 - 06/2008)
6. Cominetti, Denis: 2 articles (02/2014 - 07/2012)
7. Zaffaroni, Nadia: 2 articles (02/2014 - 07/2012)
8. Di Francesco, Angela Maria: 2 articles (12/2012 - 07/2012)
9. Meco, Daniela: 2 articles (12/2012 - 07/2012)
10. Riccardi, Riccardo: 2 articles (12/2012 - 07/2012)

Related Diseases

1. Neoplasms (Cancer)
2. Squamous Cell Carcinoma (Epidermoid Carcinoma)
3. Sarcoma (Soft Tissue Sarcoma)
4. Neutropenia
5. Febrile Neutropenia

Related Drugs and Biologics

1. namitecan
2. Camptothecin
3. Irinotecan (Camptosar)
4. Topotecan (Hycamtin)
5. 9 alpha,11 alpha,15 alpha- trihydroxy- 16- phenoxy- 17,18,19,20- tetranorprosta- 4,5,13- trienoic acid (TPT)
6. Electron Transport Complex III (Coenzyme Q-Cytochrome-c Reductase)
7. Lactones
8. Type I DNA Topoisomerases (Topoisomerase I)
9. Cetuximab (Erbitux)